10% Off
Afalino12.5 mg
Incepta Pharmaceuticals Ltd.
৳225.00
Out Of Stock
Generic medicine
Cenobamate: Brands, Price & Uses in Bangladesh
Approved Indication Cenobamate is FDA-approved as adjunctive (add-on) treatment of focal (partial-onset) seizures in adult patients.
About Cenobamate
Indications of Cenobamate
Approved Indication
Cenobamate is FDA-approved as adjunctive (add-on) treatment of focal (partial-onset) seizures in adult patients. It is used together with other antiseizure medications, not as a first-line monotherapy.
- Established use: Add-on therapy for focal-onset seizures, with or without secondary generalization, in adults whose seizures are not adequately controlled by other antiepileptic drugs (AEDs).
- Adjunct requirement: Cenobamate is studied and approved only as adjunctive therapy; it must be added to an existing antiseizure regimen rather than used alone.
- Not established: Safety and effectiveness of Cenobamate have not been established for primary generalized seizures, monotherapy use, or in pediatric patients.
Use of Cenobamate should be initiated and supervised by a physician experienced in the treatment of epilepsy.
Dosage & Administration of Cenobamate
Adjunctive Treatment of Focal Seizures (Adults)
Cenobamate must be started at a low dose and titrated slowly according to a fixed schedule; this schedule is a critical, non-negotiable safety measure to reduce the risk of DRESS (see Precautions and Warnings) and should not be shortened.
| Treatment Week | Daily Dose |
|---|---|
| Weeks 1-2 | 12.5 mg once daily |
| Weeks 3-4 | 25 mg once daily |
| Weeks 5-6 | 50 mg once daily |
| Weeks 7-8 | 100 mg once daily |
| Weeks 9-10 | 150 mg once daily |
| Week 11 onward | 200 mg once daily (recommended maintenance dose) |
| Optional further increase | May be increased by 50 mg every 2 weeks up to a maximum of 400 mg once daily, based on clinical response and tolerability |
Renal Impairment
Use with caution and consider a slower titration or lower target dose in patients with mild-to-severe renal impairment. Cenobamate is not recommended in patients with end-stage renal disease undergoing dialysis, as it has not been studied in this population.
Hepatic Impairment
In mild-to-moderate hepatic impairment, the maximum recommended dose of Cenobamate is 200 mg once daily, with consideration of further reduction. Cenobamate is not recommended in patients with severe hepatic impairment.
Discontinuation
Cenobamate should not be stopped abruptly; see Precautions and Warnings regarding withdrawal seizure risk and the need for gradual dose tapering under medical supervision.
Side Effects of Cenobamate
Common Side Effects
- Somnolence and sedation
- Dizziness
- Fatigue
- Diplopia (double vision)
- Headache
- Balance and gait disturbances (ataxia)
- Nausea/vomiting
- Blurred vision
Serious Side Effects
Cenobamate carries a boxed warning for DRESS (drug reaction with eosinophilia and systemic symptoms), a rare but potentially fatal hypersensitivity reaction, and for dose-dependent QT interval shortening; see Precautions and Warnings for full details on recognizing and managing these risks. Suicidal thoughts or behavior have also been reported, consistent with other antiepileptic drugs.
Patients should seek prompt medical attention for fever, rash, swollen lymph nodes, facial swelling, unusual bruising, or signs of organ involvement while taking Cenobamate.
Contraindications of Cenobamate
Absolute Contraindications
- Known hypersensitivity to Cenobamate or any of its formulation components.
- Familial Short QT Syndrome: Cenobamate is contraindicated in patients with this condition because its QT-shortening effect can further increase the risk of serious ventricular arrhythmias in these patients.
Other safety concerns, such as caution with additional QT-shortening drugs or hepatic/renal impairment, are managed through dose adjustment and monitoring rather than absolute contraindication; see Precautions and Warnings and Dosage and Administration.
Frequently Asked Questions about Cenobamate
What is Cenobamate used for?
Cenobamate is used as an add-on (adjunctive) treatment, together with other antiseizure medicines, to help control focal (partial-onset) seizures in adults. It is not used as a stand-alone first treatment.
Why does Cenobamate need to be started at such a low dose and increased so slowly?
The slow, multi-week dose-titration schedule for Cenobamate is a critical safety measure. Starting low and increasing gradually significantly reduces the risk of DRESS, a rare but potentially fatal hypersensitivity reaction that has occurred, including a fatality, when Cenobamate was titrated too quickly. Never speed up or skip steps in the titration schedule without your doctor's guidance.
What are the warning signs of a serious reaction to Cenobamate that I should watch for?
Seek medical attention immediately if you develop fever, skin rash, swollen lymph nodes, facial swelling, or signs of liver or kidney problems while taking Cenobamate, as these can indicate DRESS, a serious hypersensitivity reaction. Cenobamate must be stopped right away if DRESS is suspected.
Can I take Cenobamate if I have a heart condition?
Cenobamate causes dose-dependent shortening of the QT interval and is contraindicated in people with familial Short QT syndrome. Tell your doctor about any heart rhythm problems or other medicines that affect heart rhythm before starting Cenobamate, so they can assess whether it is safe for you and whether monitoring is needed.
Is it safe to take Cenobamate during pregnancy?
There is limited human data on Cenobamate use during pregnancy, and animal studies have shown some risk to the developing fetus at high doses. Cenobamate should be used in pregnancy only if your doctor determines that the benefit clearly outweighs the potential risk, since uncontrolled seizures also carry risks. Do not stop Cenobamate on your own if you become pregnant; speak with your physician first.
Can I stop taking Cenobamate suddenly if I feel better?
No. Stopping Cenobamate abruptly can trigger withdrawal seizures or worsen seizure control. If you and your doctor decide to discontinue Cenobamate, the dose must be tapered down gradually under medical supervision.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.